Stoxx Europe 50
5.108,16
PKT
+12,33
PKT
+0,24
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.03.23 | Allianz Buy | UBS AG | |
| 06.03.23 | SAP Buy | UBS AG | |
| 06.03.23 | Santander Outperform | Credit Suisse Group | |
| 06.03.23 | Siemens Energy Outperform | Credit Suisse Group | |
| 06.03.23 | BBVA Buy | UBS AG | |
| 06.03.23 | BNP Paribas Buy | UBS AG | |
| 06.03.23 | UBS Neutral | UBS AG | |
| 06.03.23 | HSBC Buy | UBS AG | |
| 06.03.23 | ING Group Buy | UBS AG | |
| 06.03.23 | Intesa Sanpaolo Buy | UBS AG | |
| 06.03.23 | Santander Buy | UBS AG | |
| 06.03.23 | UniCredit Buy | UBS AG | |
| 06.03.23 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.03.23 | Nestlé Underperform | RBC Capital Markets | |
| 06.03.23 | UBS Hold | Jefferies & Company Inc. | |
| 03.03.23 | Santander Sector Perform | RBC Capital Markets | |
| 03.03.23 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 03.03.23 | Richemont Outperform | RBC Capital Markets | |
| 03.03.23 | ING Group Buy | Jefferies & Company Inc. | |
| 03.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Hold | Jefferies & Company Inc. | |
| 03.03.23 | AXA Buy | Jefferies & Company Inc. | |
| 03.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Outperform | Bernstein Research | |
| 03.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Underperform | Credit Suisse Group | |
| 03.03.23 | Prosus Buy | UBS AG | |
| 03.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Sell | UBS AG | |
| 03.03.23 | Roche Neutral | UBS AG | |
| 03.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. | |
| 03.03.23 | BP Neutral | JP Morgan Chase & Co. | |
| 03.03.23 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 03.03.23 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 03.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Hold | Deutsche Bank AG | |
| 03.03.23 | AXA Overweight | JP Morgan Chase & Co. | |
| 03.03.23 | Allianz Neutral | JP Morgan Chase & Co. | |
| 03.03.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 02.03.23 | GSK Buy | Goldman Sachs Group Inc. | |
| 02.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Neutral | Goldman Sachs Group Inc. | |
| 02.03.23 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 02.03.23 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. |